文献速递乳房整形与再造显微修复重建

大麻使用对腹壁下深动脉穿支皮瓣自体乳房再造的影响:719例患者与1148块皮瓣分析

Impact of Cannabis Use on Deep Inferior Epigastric Perforator Autologous Breast Reconstruction: analysis of 719 patients and 1148 flaps: Impact of Cannabis Use in DIEP Reconstruction.
PubMed 文献 · Ann Plast Surg · 2025-01-01

回顾性研究纳入2015年1月至2023年12月接受腹壁下深动脉穿支皮瓣自体乳房再造的成人患者,比较大麻使用者与非使用者术后结局。大麻使用者87例(12.1%),非使用者632例。大麻使用者再入院率更高(8.0% vs 3.2%,P=0.035),末次腹部引流管拔除时间更长(21 vs 17天,P<0.001);多因素分析显示大麻使用是术后总体血肿(OR 3.078,95%CI 1.265-7.491,P=0.013)、乳房血肿(OR 3.098,95%CI 1.197-8.020,P=0.020)和再入院(OR 2.865,95%CI 1.098-7.475,P=0.031)的显著危险因素。作者认为大麻使用者接受该手术可能需要更多术后护理与关注。

要点

  • 大麻使用者再入院率8.0%,非使用者3.2%(P=0.035)。
  • 大麻使用者末次腹部引流管拔除时间21天,非使用者17天(P<0.001)。
  • 多因素分析示大麻使用与总体血肿(OR 3.078)、乳房血肿(OR 3.098)及再入院(OR 2.865)相关。

核心结论

  • 作者认为大麻使用者接受腹壁下深动脉穿支皮瓣乳房再造可能需要更多术后护理与关注。

研究设计与样本

  • 回顾性研究纳入2015年1月至2023年12月由本机构5名整形外科医生实施腹壁下深动脉穿支皮瓣自体乳房再造的成人患者,分为大麻使用者和非使用者两组,进行单变量和多变量分析。

主要发现

  • 共纳入大麻使用者87例(12.1%)和非使用者632例。
  • 2015年至2023年大麻使用者比例增加5倍。
  • 大麻使用者显著更年轻(47.5岁 vs 51.7岁,P<0.001),体重指数显著更高(30.5 vs 28.9,P=0.012)。
  • 术后大麻使用者再入院率显著更高(8.0% vs 3.2%,P=0.035),末次腹部引流管拔除时间更长(21天 vs 17天,P<0.001)。
  • 控制混杂因素后,多因素逻辑回归显示大麻使用是术后总体血肿(OR 3.078,95%CI 1.265-7.491,P=0.013)、乳房血肿(OR 3.098,95%CI 1.197-8.020,P=0.020)和再入院(OR 2.865,95%CI 1.098-7.475,P=0.031)的显著危险因素。

临床怎么用

  • 作者认为大麻使用者接受腹壁下深动脉穿支皮瓣乳房再造可能需要更多术后护理与关注。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Given recent efforts to legalize and decriminalize recreational marijuana, its use has become increasingly common in the plastic surgery patient population. Although cannabis use has generally been considered lower risk than use of other recreational substances, recent studies have suggested it may be associated with an increased surgical complication rate. The aims of our study were to (1) characterize the extent of cannabis use and (2) determine the clinical effects of cannabis use in our cohort of patients undergoing autologous breast reconstruction using deep inferior epigastric perforator (DIEP) flaps. METHODS: A retrospective study was conducted in adult patients who underwent autologous breast reconstruction using DIEP flaps between January 2015 and December 2023 by 5 plastic surgeons at our institution. Patients were divided into 2 groups of cannabis users and nonusers. Univariate and multivariable analyses were performed to assess outcomes between the groups. RESULTS: A total of 87 cannabis users (12.1%) and 632 nonusers were included. A 5-fold increase in the proportion of cannabis users from 2015 to 2023 was found. Cannabis users were significantly younger (47.5 vs 51.7, P < 0.001) and had a significantly higher body mass index (30.5 vs 28.9, P = 0.012). Postoperatively, cannabis users had a significantly higher readmission rate (8.0% vs 3.2%, P = 0.035) and longer time to last abdominal drain removal (21 vs 17 days, P < 0.001). After controlling for confounders, multivariable logistic regression revealed cannabis use as a significant risk factor for postoperative general hematoma (OR: 3.078, confidence interval [95% CI]: 1.265-7.491, P = 0.013), breast hematoma (OR: 3.098, 95% CI: 1.197-8.020, P = 0.020), and readmission (OR: 2.865, 95% CI: 1.098-7.475, P = 0.031). CONCLUSION: To our knowledge, this is the largest study examining the effects of cannabis use in patients receiving DIEP breast reconstruction. Our findings suggest that cannabis users undergoing DIEP breast reconstruction may require greater postoperative care and attention.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Park JB, Escobar-Domingo MJ, Tobin M, et al. Impact of Cannabis Use on Deep Inferior Epigastric Perforator Autologous Breast Reconstruction: analysis of 719 patients and 1148 flaps: Impact of Cannabis Use in DIEP Reconstruction. Ann Plast Surg. 2025. PMID: 40167070. doi:10.1097/SAP.0000000000004214

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。